Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
PR Newswire —
Issued on behalf of Avant Technologies Inc. Equity Insider News Commentary VANCOUVER, BC, Jan. 26, 2026 /PRNewswire/ -- The medical world is shifting as the global market for next-gen treatments heads toward $88.85 billion by 2030[1], driven by a surge in funding for high-tech cures for...